You searched for "care"
NICE - what we need to know?
The National institute for Health and Care Excellence (NICE) reached 17 years old in April 2016. As clinicians, we are reading and discussing NICE guidelines on a daily basis in multidisciplinary team meetings. NICE is always in the news, whether...The Malcolm Coptcoat Travelling Fellowship Award
The Urology Foundation and The Malcolm Coptcoat Trust are pleased to announce the creation of The Malcolm Coptcoat Travelling Fellowship. The annual Fellowship will support travel to international centres of excellence for a period of four to six weeks to...Occupational tumours of the urinary tract: The work of Denis Poole-Wilson
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). In the last article I said I would be taking you to the...
Optimisation of childhood spina bifida management – a prospective trial
Routh et al. describe a prospective trial which aims to determine the optimal urological management for children with spina bifida. The primary aim of neuropathic bladder management is to provide the patient with the best long-term quality of life with...Femeda commence innovative real world clinical trial for Pelviva
A major 330 patient randomised ‘real world’ clinical trial has commenced for Pelviva in conjunction with the University of Manchester and South Manchester GP federation. The trial will compare Pelviva against...How to organise a urology taster week as a foundation trainee
Current exposure to urology in medical undergraduate curriculums is relatively sparse in comparison to the other surgical specialties with one study reporting just 42% of students having a compulsory attachment. These attachments were an average length of just one week...Ambulatory local anaesthetic implantation of percutaneous sacral nerve stimulators
Background The current treatment paradigm for detrusor overactivity (DO) and dysfunctional voiding (DV) includes conservative measures, pharmacotherapy, intravesical onabotulinum toxin A (Botox®), sacral nerve modulation (SNM / SNS) and urinary diversion as a last resort [1]. Incidence of DO is...
The role of dutasteride in the prevention of clinical progression in asymptomatic BPH
Following the old adage ‘prevention is better than cure’, this Canadian group performed a post hoc analysis of information gained from the multicentre Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study to evaluate whether dutasteride could decrease the incidence...
Bladder urothelial neoplasms in children
Urothelial bladder neoplasms are rare in children, occurring in 0.1-0.4% of the population before the age of 20. There are no current paediatric guidelines to their management. This study retrospectively reviews the files of patients from three tertiary centres between...
